Support services, bioinformatics scientist 2 for the cancer data science laboratory, center for cancer research, national cancer institute

Ended Awarded Last action

Contract number
75N91022F00001
Awardee
Awarding agency
Obligated
$71,010

Award facts

Contract value 28% obligated
  • $71,010.00 Current, with exercised options
  • $251,393.80 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Labor Hours
Place of performance
Red Bank, NJ, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00001 · Exercise option 1: 03/12/2022 - 08/11/2022, bioinformatics scientist 2 for the cancer data science laboratory, CCR $35,505
Original award $35,505

About this award

This is a federal contract award from the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services, to Astrix Technology LLC, doing business as Astrix Technology Group. The $251,393.80 award is for support services, including a bioinformatics scientist, to assist the NCI's Cancer Data Science Laboratory. The contract was issued as a Blanket Purchase Agreement (BPA) call under Astrix's existing $19 million multi-award schedule contract with NIH to provide scientific and research support services. The contract has a period of performance through August 2024 and does not have a set-aside designation. Astrix Technology, a market leader in scientific and technical staffing, has previously supported various NIH institutes and centers by providing personnel and services to advance biomedical research.

Subawards

Subcontractor Amount Awarded
American College Of Radiology LOW-DOSE COMPUTED TOMOGRAPHY IMAGES AND CORRESPONDING DATA BOOZ ALLEN HAMILTON INC BPA CALL 75N91022F00001 POP 9/16/22-9/15/2025 / LINE 1: DIRECT LABOR ACR will… $4,544,818
Health Research, Inc. THE PURPOSE OF THIS CONTRACT MODIFICATION IS TO UPDATE THE KEY PERSONNEL REMOVING DR. JEWELL SCOTT AS PRIMARY INVESTIGATOR REPLACING HIM WITH DR. BRUCE… $429,384

Quick answers

Who was awarded contract 75N91022F00001?

75N91022F00001 was awarded to Astrix Technology LLC by National Cancer Institute (National Institutes of Health) on October 12, 2021.

How much is contract 75N91022F00001 worth?

The government has obligated $71,010 on 75N91022F00001. Its potential value, with all options, is $251,394.

Is contract 75N91022F00001 an order under another contract?

Yes. 75N91022F00001 is a BPA call under GS07F147DA-HHSN261201700002B, a blanket purchase agreement, on Multiple Award Schedule (MAS).

Was contract 75N91022F00001 competed?

The extent of competition for 75N91022F00001 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award